News

CA Inc. to Pay $45 Million to Settle VSG Qui Tam Whistleblower Case Alleging False Claims to GSA

The U.S. Department of Justice announced on March 10, 2017 that it has settled a VSG qui tam (whistleblower) False Claims Act lawsuit alleging that CA, Inc., a Fortune 500 company headquartered in Islandia, NY and a major supplier of software to federal agencies, knowingly misrepresented its pricing and discounting practices during price negotiations with the General Services Administration…

0 comments

Rob Vogel quoted in Bloomberg on court opinion in Lance Armstrong qui tam case

VSG partner Rob Vogel was quoted in a Bloomberg news article published on February 14, 2017, discussing a recent opinion by the United States District Court for the District of Columbia in a False Claims Act case, United States ex rel. Floyd Landis v. Tailwind Sports Corp., 10-cv-00976 (D.D.C.).   In its opinion, the district court…

0 comments

VS&G Qui Tam Client Sues Rite Aid Pharmacy for Usual and Customary Charge Violations

On January 19, 2017, the federal district court for the Eastern District of Michigan unsealed a qui tam action filed by VS&G’s client, Adam Rahimi, against the Rite Aid Corporation, accusing the national pharmacy chain of illegally charging individuals insured by Medicaid and Medicare more than other customers for hundreds of prescription drugs over a…

0 comments

VSG Partner Rob Vogel Speaks at Qui Tam Enforcement Conference in New York

On January 30, 2017, VSG partner Rob Vogel was featured as a speaker at the 4th Advanced Forum on False Claims & Qui Tam Enforcement, a legal education conference in New York City sponsored by the American Conference Institute. Mr. Vogel’s presentation, the “View from the Relator’s Bar,” discussed ways in which relators’ lawyers choose,…

0 comments

Justice Department Announcement on 2016 Qui Tam Settlements Highlights VSG Lawsuit

The Department of Justice announced in a recent press release that its False Claims Act settlements in Fiscal Year 2016 exceeded $4.7 billion. The Department identified the $390 million settlement in VSG’s qui tam lawsuit filed in the Southern District of New York against Novartis Pharmaceutical Corporation as one of the top recoveries in 2016….

0 comments

VSG Client David Kester Honored as “Whistleblower of the Year”

Washington, D.C., September 15, 2016: The national, non-profit, public interest organization Taxpayers Against Fraud Education Fund (TAFEF) today presented David Kester with its “Whistleblower of the Year” Award, announced Shelley R. Slade of Vogel, Slade & Goldstein, LLP. The firm represented Mr. Kester in a qui tam lawsuit against pharmaceutical giant Novartis and specialty pharmacies…

0 comments

VSG Pursues Lawsuit Against Social Security Administration

WASHINGTON, D.C. Vogel, Slade & Goldstein is continuing to pursue its class lawsuit against the Social Security Administration (SSA) in an appeal to the United States Court of Appeals for the Fourth Circuit. Hart, et al. v. Colvin, No. 16-1371 (4th Cir.). The lawsuit, Grice, et al. v. Colvin, Civ. Action 14-1082 (D.Md.), alleges that…

0 comments

1st Circuit Victory for VSG Client

In a significant victory for Vogel, Slade, & Goldstein client Robert Gadbois, as well as qui tam plaintiffs in general, the First Circuit Court of Appeals ruled in United States ex rel. Gadbois v. Pharmerica Corporation, 2015 U.S. App. LEXIS 21841 (1st Cir. Dec. 16, 2015) that a qui tam plaintiff may utilize Federal Rule…

0 comments

VS&G Partners Named to Best Whistleblower Lawyers List

Washingtonian magazine has named all three Vogel, Slade & Goldstein partners – Robert L. Vogel, Shelley R. Slade and Janet L. Goldstein — to its 2015 “Best Whistleblower Lawyer” list. The three were named “Stars of the Bar” in the top whistleblower lawyer category published in the December 2015 issue of the Washingtonian. Attorneys Vogel, Slade and…

0 comments

In Major Victory for Whistleblower David Kester, USA and States, Novartis Pays $390 Million to End Kickback Case

Washington, D.C. and New York: The U.S. Attorney for the Southern District of New York announced today that the United States and numerous states, including New York, will resolve for $390 million a False Claims Act lawsuit against the Swiss drug manufacturer Novartis Pharmaceuticals Corporation brought by David M. Kester, a whistleblower jointly represented by…

0 comments

U.S. Justice Department Joins False Claims Act Suit against Navy Contractor Alleging Worldwide Scheme to Overcharge Navy Ships

Whistleblower lawsuit alleges that Inchcape Shipping Services defrauded the Navy through a pattern of overcharges, kickbacks and false invoices Washington DC November 18, 2015 – The U.S. Department of Justice announced today that it has joined and elected to proceed with a “qui tam” (whistleblower) False Claims Act action alleging that Inchcape Shipping Services (ISS),…

0 comments

VSG’s Navy Bribery Whistleblower Case Settles

WASHINGTON, D.C. (August 4, 2015) Pursuant to settlement agreements between the parties, the United States District Court for the District of Rhode Island dismissed a False Claims Act lawsuit brought by two clients of the whistleblower law firm Vogel, Slade and Goldstein to redress a Navy bribery scheme that dissipated an estimated $18 million in…

0 comments

Government Settles VSG Qui Tam Kickback Case with Accredo Pharmacy for $60 million

Accredo resolves for $60 million VS&G client qui tam claims alleging pharmacy received rebates and patient referrals in exchange for drug recommendations On May 1, 2015, the specialty pharmacy chain Accredo Health Group, Inc. resolved for $60 million qui tam claims brought by VS&G client David Kester in a False Claims Act lawsuitthat also named…

0 comments

Court Rules VS&G Qui Tam Whistleblower Lawsuit against Software Giant CA, Inc. May Go Forward

Washington, D.C., March 31, 2015. The U.S. District Court for the District of Columbia denied a motion to dismiss filed by CA, Inc., and ruled that qui tam whistleblower Dani Shemesh could continue to pursue his False Claims Act lawsuit alleging that CA violated the False Claims Act by making misrepresentations to the Government in…

0 comments

Court Rules that Lawsuit Against Social Security Administration May Go Forward

WASHINGTON, D.C. (March 31, 2015) A federal judge has ruled that a lawsuit against the Social Security Administration (SSA) filed by Vogel, Slade & Goldstein attorney Rob Vogel may proceed. The lawsuit, filed as a class action complaint, alleges that the SSA wrongfully seized the tax refunds of hundreds of thousands of people to repay Social…

0 comments

Government Joins Whistleblower Lawsuit by VS&G Client Alleging Computer Sciences Corp. & NYC Defrauded Medicaid

New York, October 28, 2014 — The federal government and New York State have joined a qui tam whistleblower lawsuit filed in 2012 by a former Computer Sciences Corporation (CSC) employee represented by Washington, D.C. law firm Vogel, Slade & Goldstein.   The federal government has joined claims that VS&G’s client brought against New York City…

0 comments

Whistleblower Receives $2.79 Million in Settlement of Medicare Fraud and Retaliation Lawsuit Against Extendicare

Former Employee’s Qui Tam Lawsuit Leads to $10 Million Taxpayer Recovery From Nursing Home Chain  Washington, D.C., October 10, 2014. Whistleblower Tracy Lovvorn, represented jointly by the qui tam law firm Vogel, Slade & Goldstein, and Katz, Marshall & Banks, announced today that she has settled her claims of Medicare fraud and retaliation for just under $2.8 million….

0 comments

Former Sales Manager Files Whistleblower Complaint Against Novartis

Justice Department, 10 states join lawsuit alleging pharmaceutical giant ran massive kickback scheme with multiple pharmacies to boost sales of its patented drugs despite known side effects. A former Novartis sales manager has filed a whistleblower complaint alleging that the pharmaceutical giant engaged in a massive kickback scheme to unlawfully induce CVS Caremark and other pharmacies…

0 comments

Whistleblower Lawsuit in Navy Kickbacks Continues

Vogel, Slade & Goldstein, along with their clients Karan and Rekha Vasudeva, continue to pursue the qui tam action that led to the convictions of six defendants in the District of Rhode Island for bribery and theft of Navy funds. Three defendants are now serving prison terms in Rhode Island, and three will face probation…

0 comments

DOJ Joins VS&G Client Lawsuit Against For-Profit Hospital Chain & Ex-CEO for ER Admissions Scheme

Whistleblower lawsuit alleges that HMA, its former CEO Gary Newsome, and ER contractor EmCare induced and coerced ER doctors to admit more patients The U.S. Department of Justice (USDOJ) has intervened in a qui tam (whistleblower) False Claims Act lawsuit alleging that Health Management Associates, Inc. (HMA), the nation’s third-largest for-profit hospital chain, and its…

0 comments

Software Giant CA Technologies Agrees to Pay $11 million to Settle Federal and Multi-State False Claims Act Whistleblower Lawsuit for Billing Fraud

Former employee alleged the company falsely billed hundreds of public agencies at federal, state and local levels CA Technologies, a Fortune 500 company headquartered in Islandia, NY, has agreed to pay $11 million to settle whistleblower allegations that the software giant violated the federal False Claims Act and similar state and local statutes through the…

0 comments

Qui Tam Lawyers Robert Vogel, Shelley Slade & Janet Goldstein Named “Whistleblower Lawyers of the Year” by Taxpayers Against Fraud

Qui tam lawyers Rob Vogel, Shelley Slade & Janet Goldstein of the national qui tam law firm Vogel, Slade & Goldstein, LLP, have been named “Whistleblower Lawyers of the Year” by Taxpayers Against Fraud, the preeminent public interest organization dedicated to combating fraud against the government. At its annual Awards Dinner on October 24, 2013…

0 comments

J&J Pays $149 Million to Resolve VS&G Qui Tam Alleging Kickbacks to Promote Risperdal

On November 4, 2013, the U.S. Department of Justice announced that it had finalized an agreement with pharmaceutical giant Johnson & Johnson (J&J) to resolve for $2.2 billion certain criminal and civil claims arising from the company’s alleged illegal marketing of the atypical antipsychotic drug, Risperdal. This settlement resolved a number of qui tam cases…

0 comments

Whistleblower Lawyer Janet Goldstein Speaks on Litigating Qui Tam Cases at Washington DC Employment Lawyers’ Conference

Vogel Slade & Goldstein partner and whistleblower lawyer Janet Goldstein spoke about litigating qui tam cases under the False Claims Act at a National Employment Lawyers Association (NELA) conference entitled Shining the Light on Whistleblower & Retaliation Claims. Drawing upon her 20+ years of practice as a whistleblower lawyer, Ms. Goldstein shared with her audience…

0 comments

Pfizer pays $491 Million to Resolve Allegations of Off-Label Marketing of Rapamune

The United States District Court for the Western District of Oklahoma on July 30, 2013, unsealed a whistleblower lawsuit against Wyeth Pharmaceuticals Inc filed in 2007 by the national whistleblower firm Vogel, Slade & Goldstein, LLP, on behalf of Mark Campbell, a former Wyeth sales representative, that alleged that Wyeth for over a decade illegally…

0 comments

Gallup pays $10.5M to settle qui tam whistleblower case filed by VSG client

Former Employee’s Qui Tam Lawsuit Leads to Taxpayer Recovery from Market-Research Company that Billed Itself “The Most Trusted Name in Polling.” Washington, D.C. The U.S. Department of Justice (DOJ) announced today that it has reached a settlement with the Gallup Organization over charges that Gallup had violated the False Claims Act and the Procurement Integrity…

0 comments

Shelley R. Slade Testifies on Qui Tam Law & Procedures before the U.S. Congress

On May 7, 2013, Shelley R. Slade testified at a congressional hearing concerning the law and procedures pertaining to U.S. Department of Justice decisions on whether to intervene in False Claims Act qui tam cases.  Ms. Slade was invited to testify by subcommittees of the Committee on the Judiciary and the Committee on Government Oversight…

0 comments

VSG Whistleblower Lawyers in the News 2011-2013

Since the founding of Vogel, Slade & Goldstein, LLP, each of its principals has been sought out by major news outlets, law schools, legal organizations and the US Congress to provide insight and information about qui tam law and lawsuits.  The following are examples of events, organizations and media stories in which they participated: Janet Goldstein spoke on…

0 comments

Former FEMA Exec Timothy Cannon Pleads to Felony for Corruptly Steering Contracts to Gallup

Charges Arise from Whistleblower Lawsuit by former Gallup Employee Michael Lindley Former FEMA executive Timothy Cannon pleaded guilty in federal court in Washington, D.C. to a felony conflict of interest charge for steering a FEMA contract and funding to Gallup while he was negotiating a partnership position with the worldwide polling firm. Cannon faces a…

0 comments

Former FEMA Director Will Plead to Felony for Corruptly Steering Contracts to Gallup, Reports NBC News

Charges Arise from Whistleblower Lawsuit by former Gallup Employee Michael Lindley The attorney for Timothy Cannon says that the former FEMA executive will plead guilty to a felony conflict of interest charge for steering a FEMA contract and funding to Gallup while he was negotiating a partnership position with the worldwide polling firm, NBC News…

0 comments

Justice Department Sues Gallup for Defrauding Three Federal Agencies

Washington, D.C. In a 57-page civil complaint filed in federal court in Washington, D.C., the U.S. Department of Justice (DOJ) accuses The Gallup Organization of bilking the State Department and U.S. Mint out of millions of dollars by falsifying labor-hour estimates on government contract work between 2007 and 2009. DOJ’s complaint also accuses Gallup of…

0 comments

VS&G Qui Tam Lawyers Receive Top Rankings in Study of False Claims Act Whistleblower Lawsuits

Rankings Based on Study of 4000+ False Claims Act Lawsuits Brought by Qui Tam Lawyers on Behalf of Whistleblowers Vogel, Slade & Goldstein has received top rankings among the nation’s 25 most active qui tam law firms representing whistleblowers in False Claims Act lawsuits, according to a first-of-its kind study by Stanford University law professor…

0 comments

Qui Tam Whistleblower Michael Lindley Alleges Gallup Defrauded U.S. Government

Qui Tam Whistleblower Lawsuit Against Gallup Organization Joined by U.S. Government Washington, D.C.  The U.S. Department of Justice has joined a whistleblower qui tam lawsuit charging the Gallup Organization with perpetrating a multi-million dollar fraud in its contracts with the Department of the Treasury and the Department of State. The lawsuit is captioned U.S. ex…

0 comments

Johnson & Johnson Reserves Funds for Settlement

In a June 8, 2012 press release, Johnson & Johnson stated it is taking a $600 million charge for settlement of cases involving J&J kickbacks to long term care pharmacy chain Omnicare to increase sales of Risperdal and two other drugs. VS&G represents the whistleblower in one of the two qui tam cases against J&J…

0 comments

Rob Vogel of Vogel, Slade & Goldstein Comments on SEC Proposed Rule

In December 2010, Rob Vogel of Vogel, Slade & Goldstein was part of a group that submitted a Comment on the SEC’s Proposed Rule for Implementing the Whistleblower Provisions of Section 21F of the Securities Exchange Act of 1934 (amended under Title IX of the Dodd-Frank bill). Under the new Whistleblower Provisions, a person who…

0 comments

Armor Group North America and its Affiliates Pay $7.5 Million to Resolve False Claims Act Allegations

FOR IMMEDIATE RELEASE WWW.JUSTICE.GOV WASHINGTON – Armor Group North America Inc. (AGNA) and its affiliates have paid the United States $7.5 million to resolve allegations that AGNA submitted false claims for payment on a State Department contract to provide armed guard services at the U.S. Embassy in Kabul, Afghanistan, the Justice Department announced today. The…

0 comments

Bringing its False Claims Act Settlements in VS&G Lawsuits to a Total of $197.5 million, Omnicare Pays $21 million to Settle Allegations of Medicaid Fraud in Massachusetts and Michigan in Whistleblower Action

Whistleblower law firm Vogel, Slade & Goldstein, LLP announced today that, Omnicare, Inc., the nation’s leading provider of medications for nursing home residents, has paid $21,050,000.00 to settle allegations brought by a whistleblower that it defrauded the Medicaid programs of the Commonwealth of Massachusetts and the State of Michigan by knowingly charging more for drugs…

0 comments

Ivax Pharmaceuticals to Pay $14 Million to Resolve False Claims Act Lawsuit

Ivax Pharmaceuticals enters into a settlement agreement with the United States to resolveFalse Claims Act allegations. Shelley R. Slade, attorney for qui tam plaintiff David Kammerer, comments on the policy concerns and implications of the settlement. Vogel, Slade & Goldstein, LLP announced today that the United States and the law firm’s client, David Kammerer, have…

0 comments

False Claims Act Amendments Passed By Congress; Qui Tam attorney Shelley Slade Provides Key Testimony Before Congress

The U.S. Congress this evening passed S. 386, the Fraud Enforcement and Recovery Act of 2009 (FERA), legislation containing critically-needed amendments to the civil False Claims Act (FCA), 31 U.S.C. § 3729 et seq. The FCA is a law that provides the United States with a triple damage remedy when false claims and false statements…

0 comments